BCL2 and prostate cancer: In prostate cancer models, <b>14a</b> inhibited AR<sup>-</sup> and AR<sup>+</sup> cell proliferation, enhanced histone and tubulin acetylation, upregulated p21, and downregulated Bcl-2.